Condition

CANCER,NOS (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Bristol-Myers Squibb (1)

Collaborator

Intervention

ipilimumab (1)

lirilumab (1)

nivolumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

cancer,nos

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

CANCER,NOS Trial in Worldwide (Lirilumab, Nivolumab, Ipilimumab)

Completed

CANCER,NOS

Lirilumab
+2 more

San Francisco, California
+29 more

Dec 10, 2020